The lack of relationship between serum content of MBL, sCD14, anti-PPD and anti-Hsp65 IgG and ingestion of Mycobacterium bovis BCG bacilli by phagocytes

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 5, 2002, Pages 337-344

  Paziak Domańska, Beata ^a   Bonar, Agnieszka ^a   Kowalewicz Kulbat, Magdalena ^a   Klink, Magdalena ^b   Kowalski, Michał ^c   Karhukorpi, Jari ^d   Kartfunen, Ritta ^e   Jurkiewicz, Magdalena ^a   Rózalska, Barbara ^a   Rudnicka, Wiesława ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c Health Centre for High Schools   (Poland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Macrophages; Polymorphonuclear leukocytes; Tuberculin test

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; CD14 ANTIGEN; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN G ANTIBODY; MANNOSE BINDING PROTEIN; PROTEIN DERIVATIVE; BACTERIUM ANTIBODY; CHAPERONIN; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; IMMUNOGLOBULIN G; MANNOSE BINDING LECTIN; TUBERCULIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BCG VACCINATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM BOVIS; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION; TUBERCULIN TEST; ADOLESCENT; ANIMAL; BLOOD; DELAYED HYPERSENSITIVITY; IMMUNOLOGY; IN VITRO STUDY; LUNG TUBERCULOSIS; MICROBIOLOGY; SOLUBILITY;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, CD14; BACTERIAL PROTEINS; BCG VACCINE; CHAPERONINS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; MANNOSE-BINDING LECTIN; MYCOBACTERIUM BOVIS; PHAGOCYTES; PHAGOCYTOSIS; SOLUBILITY; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 1842867068     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barthel R., Piedrahita J. A., McMurray D. N., Payeur J., Baca D., Suarez Guemes F., Perumaalla V. S., Ficht T. A., Templeton J. W. and Adams L. G. (2000): Pathologic findings and association of Mycobacterium bovis infection with the bovine Nramp1 gene in cattle from herds with naturally occurring tuberculosis. Am. J. Vet. Res., 61, 1140-1144.
2. Bellamy R., Ruwende C., Corrah T., McAdam K. P. W., Whittle H. C. and Hill A. V. (1998): Variations in the Nramp1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med., 338, 640-644.
3. Bonar A., Kowalewicz M., Rudnicka W., Mackiewicz P., Krawczyk Z. and Różalska B. (2000): Wartość badań serologicznych w diagnostyce gruźlicy. Konferencja "Biologia Molekularna w Diagnostyce Chorób Zakaźnych i Biotechnologii", 9 grudnia, 2000, Warszawa. Wyd. SGGW, Warszawa, 38-41.
4. Chmiela M., Czkwianianc E., Wadstrom T. and Rudnicka W. (1997): Role of Helicobacterpylori surface structures in bacterial interaction with macrophages. Gut, 40, 20-24.
5. Corrah T., Byass P., Jaffar S., Thomas V., Bouchier V., Stanford J. L. and Whittle H. C. (2000): Prior BCG vaccination improves survival of Gambian patients treated for pulmonary tuberculosis. Tropic. Med. Inter. Health, 5, 413-417.
6. Dye C., Scheele S., Dolin P., Pathania V. and Raviglione M. C. (1999): Global burden of tuberculosis. Estimated incidence, prevalence, mortality by country. JAMA, 282, 677-686.
7. Ellner J. J. (1997): Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med., 130, 469-475.
8. Hart P. D. and Sutherland I. (1977): BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br. Med. J., 2, 293-295.
9. Hetland G., Wiker H. G., Hogasen B., Svenson S. B. and Harboe M. (1998): Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin. Diag. Lab. Immunol., 5, 211-218.
10. Jagannath C., Pai S., Actor J. K. and Hunter R. L. Jr. (1999): CRL-1072 enhances antimycobacterial activity of human macrophages through interleukin-8. J. Interferon Cytokine Res., 19, 67-76.
11. Kaufmann S. H. E. (1996): The interplay between cytokines and T cells in immunity to intracellular bacteria. In Mustafa A. S., al-Attiyah R. J., Nath J. and Chaugh T. D. (eds.): T Cell Subsets and Cytokines Interplay in Infectious Diseases. Karger, Basel, Switzerland, 169-180.
12. Kelly P., McKeown D. and Clancy L. (1997): Neonatal BCG vaccination in Ireland: Evidence of its efficacy in the prevention of childhood tuberculosis. Eur. Respir. J., 10, 619-623.
13. Matsushita M. and Fujita T. (1992): Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med., 176, 1497-1502.
14. Ng T. T., Strang J. I. and Wilkins E. G. (1994): Humoral response to mycobacterial heat shock proteins in patients with constructive pericarditis caused by tuberculosis and its implications in pathogenesis. Clin. Diag. Lab. Immunol., 1, 552-555.
15. North R. J. and Medina E. (1996): Significance of the antimicrobial resistance gene, Nramp1, in resistance to virulent Mycobacterium tuberculosis infection. Res. Immunol., 147, 493-499.
16. Perskvist N., Zheng L. and Stendahl O. (2000): Activation of human neutrophils by Mycobacterium tuberculosis H37Ra involves phospholipase Cγ2, Shc adapter protein, and p38 mitogen activated protein kinase. J. Immunol., 164, 959-965.
17. Peterson P. K., Gekker G., Hu S., Sheng W. S., Anderson W. R., Ulevitch R. J., Tobias P. S., Gustafson K. V., Molitor T. W. and Chao C. (1995): C14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun., 63, 1598-1602.
18. Petrofsky M. and Bermudez L. E. (1999): Neutrophils from Mycobacterium avium infected mice produce TNF-α, IL-12, and IL-1β and have a putative role in early host response. Clin. Immunol., 91, 354-358.
19. Polotsky V. Y., Belisle J. T., Mikusova K., Ezekowitz R. A. and Joiner K. A. (1997): Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis., 175, 1159-1168.
20. Rudnicka W., Brzychcy M., Klink M., Gomez-Lopez A., Fonteyne P.-A., Rusch-Gerdes S. and Rozalska B. (1999): The production of nitric oxide and tumor necrosis factor by murine macrophages infected with mycobacterial strains differing by hemolytic activity. Microbiol. Immunol., 43, 637-644.
21. Schlesinger L. S. (1998): Mycobacterium tuberculosis and the complement system. Trends Microbiol., 47, 49-50.
22. Shaw M. A., Collins A., Peacock C. S., Miller E. N., Black G. F., Sibthorpe D., Lins-Lainson Z., Shaw J. J., Ramos F., Silveira F. and Blackwell J. M. (1997): Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFα. Tubercle Lung Dis., 78, 35-45.
23. Tuberculosis Prevention Trial, Madras (1980): Trial of BCG vaccines in South India for tuberculosis prevention. Indian J. Med. Res., 72 (suppl. 1) 1-74.
24. Turner M. W. (1996): Mannose-binding lectin: The pluripotent molecule of the innate immune system. Immunol. Today, 17, 532-540.
25. Vidal S., Gros P. and Skamene E. (1995): Natural resistance to infection with intracellular parasites: Molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukoc. Biol., 58, 382-390.
26. Wang J., Wakeham J., Harkness R. and Xing Z. (1999): Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Invest., 103, 1023-1029.
27. Xu D. L., Goto Y., Endo F., Amoako K. K. and Shinjo T. (1997): The effect of Bcg gene on antigen presentation of spleen adherent cells and peritoneal macrophages from Mycobacterium bovis BCG-infected Bcg (s) and Bcg (r) mice. Vet. Microbiol., 59, 67-78.
28. Zlotta A. R., Drowart A., Huygen K., de Bruyn J., She-karsari H., Decock M., Pirson M., Jurion F., Palfleit K., Denis O., Mascart F., Simon J., Schulman C. C. and Van Vooren J. P. (1997): Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guerin (BCG) in patients with superficial bladder cancer. Clin. Exp. Immunol., 109, 157-165.